Despite guideline recommendations, the use of bioprosthetic heart valves has surpassed mechanical valves, but data from a large surgical database may lead to a reassessment of that practice.

Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.

New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...

Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company ...

The Heart Valve Devices Market is driven by advancements in aortic, mitral, tricuspid, and pulmonary valve technologies. It ...

When Nate and Marion Weeks got married 35 years ago, little did they know they’d each undergo heart surgery performed by the same doctor 18 years apart.

House Democratic Rep. John Larson says cause of pausing episode during House floor speech ruled to have been a complex partial seizure.

Background Aortic stenosis is a degenerative condition with high mortality in its severe stages and no preventive treatment.

Kennesaw State University mechanical engineering professor Philippe Sucosky has earned a prestigious American Heart ...

Edwards Lifesciences Corp.’s posted fourth quarter results slightly ahead of expectations, but indicated that the first quarter of 2025 might not be as bright. The company expects growth for both its ...